Skip to main content
TKNO logo

TKNO · Alpha Teknova, Inc.

$5.42 +0.10 (+1.88%) At close · Jul 17
Market Cap
$290.59M
Shares
53,614,028

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$40.52M +7.4%
FY2025 Revenue FY2021–FY2025
Net Income
-$17.26M +35.5%
FY2025 Net Income FY2021–FY2025
Gross Margin
33.17% +14pp
FY2025 Gross Margin FY2021–FY2025
Operating Margin
-41.9% +27.4pp
FY2025 Operating Margin FY2021–FY2025
Diluted EPS
-$0.32 +43.9%
FY2025 Diluted EPS FY2021–FY2025
Operating Cash Flow
-$8.65M +30.2%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021
$41.8M $40.52M $37.75M $36.68M $41.42M $36.89M
-$785K -$710K -$687K -$833K $213K -$589K
$27.58M $27.08M $30.51M $26.39M $23.94M $19.27M
$14.22M $13.44M $7.23M $10.3M $17.48M $17.62M
33.17% 19.16% 28.07% 42.19% 47.76%
$2.25M $2.2M $2.76M $5.57M $7.74M $4.31M
$7.24M $6.75M $6.32M $9.33M $9.15M $3.78M
$19.88M $20.32M $23.15M $25.45M $28.3M $20.39M
$1.15M $1.15M $1.15M $1.15M $1.15M $1.15M
$6.34M $6.58M $5.66M $3.17M $2.88M
$30.53M $30.42M $33.38M $45.86M $67.14M $29.63M
-$16.31M -$16.98M -$26.15M -$35.56M -$49.66M -$12.01M
-41.9% -69.27% -96.94% -119.89% -32.55%
-$10.63M -$19.57M -$29.9M -$46.49M -$9.13M
-$776K -$225K -$687K -$1.52M $268K -$629K
-$17.09M -$17.2M -$26.83M -$37.08M -$49.39M -$12.64M
$83K $58K -$88K -$298K -$1.92M -$2.83M
-$17.17M -$17.26M -$26.75M -$36.78M -$47.47M -$9.8M
-42.59% -70.86% -100.26% -114.6% -26.57%
-$9.8M
USD/shares -$0.32 -$0.57 -$1.16 -$1.69 -$0.61
USD/shares -$0.32 -$0.57 -$1.16 -$1.69 -$0.61
shares 53.48M 46.75M 31.82M 28.08M 16.09M
shares 53.48M 46.75M 31.82M 28.08M 16.09M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Drug Manufacturers - Specialty & Generic median 2.24×
EV/EBIT
Drug Manufacturers - Specialty & Generic median 34.87×
P/E (TTM)
Drug Manufacturers - Specialty & Generic median 20.52×

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Geography (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
United States $38,249,000 $35,919,000 $35,000,000 $40,103,000 $35,808,000 $30,138,000
Non Us $2,271,000 $1,826,000 $1,684,000 $1,317,000 $1,085,000 $1,159,000

By Product & Service (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Lab Essentials $31,044,000 $28,883,000 $28,800,000 $31,772,000 $27,184,000 $21,240,000
Clinical Solutions $7,650,000 $7,097,000 $6,738,000 $8,445,000 $6,793,000 $4,807,000
Other Product $1,826,000 $1,765,000 $1,146,000 $1,203,000 $1,386,000 $953,000
Sample Transport $1,530,000 $4,297,000
Key facts CIK 1850902 CUSIP 02080L102 13F (30d) 3 filings 3 filers Visit website Investor relations